Detalhe da pesquisa
1.
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.
Cell
; 184(9): 2316-2331.e15, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773105
2.
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.
Cell
; 184(7): 1804-1820.e16, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691139
3.
The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell
; 184(8): 2183-2200.e22, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33756110
4.
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.
Cell
; 182(3): 744-753.e4, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32553273
5.
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
Cell
; 183(1): 169-184.e13, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32931734
6.
Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
Nat Immunol
; 21(11): 1470, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32879513
7.
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
Nat Immunol
; 21(11): 1327-1335, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839612
8.
A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection.
Nat Immunol
; 20(10): 1291-1298, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31477918
9.
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires.
Cell
; 166(6): 1471-1484.e18, 2016 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27610571
10.
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope.
Immunity
; 54(10): 2399-2416.e6, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34481543
11.
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants.
Immunity
; 54(9): 2159-2166.e6, 2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464596
12.
SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2.
Immunity
; 54(6): 1304-1319.e9, 2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34048708
13.
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.
Nature
; 596(7870): 109-113, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34182569
14.
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.
Nature
; 596(7870): 103-108, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34153975
15.
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
Nature
; 583(7815): 290-295, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32422645
16.
Potently neutralizing and protective human antibodies against SARS-CoV-2.
Nature
; 584(7821): 443-449, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668443
17.
prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis.
Proc Natl Acad Sci U S A
; 120(3): e2218899120, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36638211
18.
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
Proc Natl Acad Sci U S A
; 118(38)2021 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34470866
19.
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
J Virol
; 96(1): e0151121, 2022 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668780
20.
Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2.
Proc Natl Acad Sci U S A
; 117(34): 20803-20813, 2020 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32764148